CHO Pharma, Inc. Stock

Equities

6586

TW0006586001

Pharmaceuticals

End-of-day quote Taipei Exchange 06:00:00 2024-06-06 pm EDT 5-day change 1st Jan Change
55 TWD -0.54% Intraday chart for CHO Pharma, Inc. +1.10% -20.63%
Sales 2022 60K 1.85K Sales 2023 - Capitalization 14.83B 458M
Net income 2022 -338M -10.43M Net income 2023 -306M -9.45M EV / Sales 2022 402,853 x
Net cash position 2022 1.03B 31.88M Net cash position 2023 2.6B 80.35M EV / Sales 2023 -
P/E ratio 2022
-74.5 x
P/E ratio 2023
-43.3 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 100%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.54%
1 week+1.10%
Current month+0.92%
1 month+1.29%
3 months-10.71%
6 months-23.08%
Current year-20.63%
More quotes
1 week
54.10
Extreme 54.1
59.00
1 month
53.00
Extreme 53
59.00
Current year
51.70
Extreme 51.7
70.20
1 year
51.70
Extreme 51.7
90.60
3 years
34.85
Extreme 34.85
251.50
5 years
12.90
Extreme 12.9
251.50
10 years
12.90
Extreme 12.9
251.50
More quotes
Managers TitleAgeSince
Chief Executive Officer - -
Chairman - 17-12-26
Director of Finance/CFO - 16-03-27
Members of the board TitleAgeSince
Director/Board Member 67 13-05-26
Director/Board Member - 19-06-05
Chairman - 17-12-26
More insiders
Date Price Change Volume
24-06-07 55 -0.54% 210,059
24-06-06 55.3 -3.32% 456,012
24-06-05 57.2 +5.54% 886,936
24-06-04 54.2 -0.37% 245,385

End-of-day quote Taipei Exchange, June 06, 2024

More quotes
CHO PHARMA INC. is principally engaged in the development of new drugs related to sugar molecules. The company’s technology and development can be divided into eight categories according to its patent features, including homogeneous antibody drugs, monoclonal antibodies of cancers and immune-related diseases, carbohydrate-related vaccines and drugs, anti-influenza drugs, the development and application of Saccharin tablets, the development and application of sugar probes, the synthesis identification development and application of sugar molecular, as well as the derivative patents of innovation development plans.
More about the company